Table 2: Serum levels of hemoglobin, hematocrit and ferritin, mean corpuscular volume and transferrin saturation in both groups.
Group I (n = 367) | Group II (n = 149) | p-value | |
Pre-treatment hemoglobin (g/dl) | 9.33 ± 1.35 | 8.98 ± 1.28 | 0.010* |
Pre-treatment hematocrit (%) | 31.13 ± 3.85 | 30.25 ± 3.56 | 0.022* |
Pre-treatment MCV (fl) | 73.78 ± 10.10 | 71.93 ± 9.01 | 0.064 |
Pre-treatment ferritin (ng/mL) | 4.50 (1.20-25.10) | 4.00 (1.00-25.00) | 0.016* |
Pre-treatment transferrin saturation (%) | 7.00 (1.00-18.00) | 6.00 (1.00-15.00) | 0.002* |
Post-treatment hemoglobin (g/dl) | 11.97 ± 1.36 | 12.31 ± 1.35 | 0.016* |
Post-treatment hematocrit (%) | 38.2 ± 4.01 | 39.2 ± 4.07 | 0.016* |
Post-treatment MCV (fl) | 82.62 ± 7.06 | 83.7 ± 6.54 | 0.125 |
Post-treatment ferritin (ng/mL) | 94.55 (24.30-69.90) | 115.40 (26.70-42.00) | 0.024* |
Post-treatment transferrin saturation (%) | 22.50 (5.00-60.0) | 24.00 (5.00-59.00) | 0.163 |
Time for evaluation of treatment response | 4.00 (3.00-6.00) | 4.00 (3.00-6.00) | 0.065 |
(Hint: Data expressed as mean ± SD or median (min-max); *: statistically significant at p < 0.05); (MCV: mean corpuscular volume).